Casdin Capital
68 portfolio companies · 12 on the map · $1.9B raised · 11 cities
Portfolio map
11 Casdin Capital portfolio companies on the map.
Portfolio companies

insitro
South San Francisco
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Biotechnology Research$643MEst. 2018
Absci
Vancouver
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Biotechnology Research$394.3MEst. 2011
Codexis
Redwood City
Codexis is a biosciences company applying synthetic chemistry technologies to create improved versions of small molecule therapeutics.
Biotechnology Research$219.3MEst. 2002
908 Devices
Burlington
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Manufacturing$167.8MEst. 2012
Imagen Technologies
New York
Imagen is a healthcare organization that provides onsite and diagnostic solutions to maximize clinical outcomes and patient satisfaction.
Hospitals and Health Care$134.3MEst. 2015
Apella
San Francisco
Apella is a technology company for better surgery. We use artificial intelligence, computer vision, and modern communications to improve the most critical aspect of healthcare.
Hospitals and Health Care$104MEst. 2020
Dyno Therapeutics
Massachusetts
Dyno Therapeutics builds AI-driven genetic technologies at the intersection of AI and genetic medicine, uniting biologists, engineers, software developers, data scientists, and machine learning experts to accelerate transformative genetic s
Biotechnology$100MEst. 2018
Leyden Labs
Leiden
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Biotech$58.9MEst. 2020
Nomic Bio
Montreal
Nomic develops a high-throughput proteomics platform to profile proteins at large scale, making biology easier to measure. Spun from McGill University, it is headquartered in Montreal with a Boston facility, partners with pharma including G
Biotechnology$42M
Volta Labs
Boston
Volta Labs, based in Boston’s Seaport, is a genomics applications company developing a digital fluidics platform to maximize performance and scalability of sample preparation, aiming to make extracting information from biological samples as
Biotechnology$20MEst. 2018
Octave
Mechelen
Mechelen-based · energy.
Energy$750KEst. 2020
Multiply Labs
San Francisco
Multiply Labs, a 36-person San Francisco-based company founded in 2016 by Fred Parietti and Alice Melocchi, delivers pharmaceutical automation via a pharma robotics as a service model, enabling life-saving therapies and partnering with glob
Pharmaceutical ManufacturingSeries AEst. 2016
More portfolio companies
53 more Casdin Capital investments we track beyond the map — 68 tracked in total.
Nautilus BiotechnologySan Carlos · Post-IPO Equity
Oxford Nanopore TechnologiesOxford · Series H
Beacon BiosignalsBoston · Series B
23andMeSunnyvale · Post-IPO Equity
GeneDxStamford · Post-IPO Equity
Singular GenomicsLa Jolla · Series B
Genome MedicalSouth San Francisco · Series C
ResilienceLa Jolla · Series D
AsimovBoston · Series B
SomaLogicBoulder · Post-IPO Equity
Flatiron HealthNew York · Series C
Treeline BiosciencesWatertown · Series A
DeepcellMenlo Park · Series B
MOMA TherapeuticsCambridge · Series B
VinetiOakland · Series C
Verve TherapeuticsBoston · Series B
Verana HealthSan Francisco · Series E
Komodo HealthSan Francisco · Series E
Auron TherapeuticsNewton · Series B
Flare TherapeuticsCambridge · Series B
Character BiosciencesJersey City · Series A
Revolution MedicinesRedwood City · Series C
Avidity BiosciencesSan Diego · Post-IPO Equity
GenomaticaSan Diego · Series C
NeoGenomicsFort Myers · Post-IPO Equity
Beam TherapeuticsCambridge · Post-IPO Equity
Exai BioPalo Alto · Series A
GenapsysRedwood City · Series C
TMRW Life SciencesNew York · Series D
Vanqua BioChicago · Series B
C2i GenomicsNew York · Series B
Ventus TherapeuticsWaltham · Series C
NanoCellect BiomedicalSan Diego · Series D
Molecular AssembliesSan Diego · Series B
Mnemo TherapeuticsParis · Series A
Notch TherapeuticsToronto · Series A
T-knifeBerlin · Series B
DepixusCourbevoie · Series A
Exo TherapeuticsCambridge · Series B
LetsGetCheckedAtlanta · Series D
PaigeNew York · Series C
Adaptive BiotechnologiesSeattle · Series F
Black Diamond TherapeuticsCambridge · Series C
iVexSolLexington · Series A
Loop MedicalLausanne · Series A
ONIOxford · Series B
Standard BioToolsSouth San Francisco · Post-IPO Equity
Generation BioCambridge · Series C
Jounce TherapeuticsCambridge · Series B
Basilard BioTechCalifornia · Seed
Magenta TherapeuticsCambridge · Series C
Foundation MedicineCambridge · Series B
MyoKardiaBrisbane · Series B
Portfolio map
11 Casdin Capital portfolio companies on the map.